Recently, we studied the cellular population structure of AD brains of carriers of Mendelian mutations in APP, PSEN1, and PSEN2, and sporadic ADs and compared them to neuropathology-free controls [4]. This evidence concerns the gene PSEN2 and Alzheimer disease.